News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
December, 2024
December 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC
Aikaterini Semilietof/LinkedIn
Dec 26, 2024, 15:46

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. – JITC

A recent paper by Aikaterini Semilietof, Postdoctoral Scholar at the JITC, was mentioned by Journal for ImmunoTherapy of Cancer on X:

“New JITC article.”

“Preclinical model for evaluating human TCRs against chimeric syngeneic tumors”

Authors: Aikaterini Semilietof, Evangelos Stefanidis, Elise Gray-Gaillard, Julien Pujol, Alessia D’Esposito, Patrick Reichenbach, Philippe Guillaume, Vincent Zoete, Melita Irving, Olivier Michielin.

Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. - JITC

More posts featuring Journal for ImmunoTherapy of Cancer.

Aikaterini Semilietof Alessia D'Esposito cancer Elise Gray-Gaillard Evangelos Stefanidis JITC Journal for ImmunoTherapy of Cancer Julien Pujol Melita Irving Olivier Michielin OncoDaily Oncology Patrick Reichenbach Philippe Guillaume Vincent Zoete
Special Coverage
Science
Dec 26, 2024, 15:46
Preclinical model for evaluating human TCRs against chimeric syngeneic tumors by Aikaterini Semilietof et al. - JITC
Insight
Dec 26, 2024, 15:33
Tumors in Black patients with cancer are more likely to exhibit whole-genome duplication - Yale School of Medicine
Science
Dec 26, 2024, 15:25
CT-Based Body Composition and Frailty as Predictors of Survival Among Older Adults With GI Malignancies
Insight
Dec 26, 2024, 15:22
Ilias Houda: Our EORTC survey on resectability of stage III NSCLC
Positive
Dec 26, 2024, 15:12
Celebrating the Holiday Magic with Medical Community
Insight
Dec 26, 2024, 15:10
Eliminating cancer with nivolumab and the chemotherapy regimen AVD - NCI
Insight
Dec 26, 2024, 15:06
Julian Downward: Compounds that block the interaction of RAS proteins with PI3-kinase
Science
Dec 26, 2024, 15:03
Myeloma Paper of the Day, December 26th, suggested by Robert Orlowski
Insight
Dec 26, 2024, 15:03
Amol Akhade: Adjuvant nivolumab in Muscle-Invasive Urothelial Carcinoma
Blog
Dec 26, 2024, 14:55
Jonathan Govette: Wishing everyone a joyful holiday season from Oatmeal Health
Blog
Dec 26, 2024, 14:51
James Crowley: The many challenges of the Harvard-Dana Farber Center by David Nathan
Blog
Dec 26, 2024, 14:47
Rahul Purwar: Make in India CAR-T Cells Gene therapy accessible to all patients